Conexeu Sciences Inc. (CNXU) vs Humacyte, Inc. (HUMA)

A side-by-side comparison of Conexeu Sciences Inc. and Humacyte, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

CNXU

Conexeu Sciences Inc.

$99M

$3.71HealthcareDelayed quote: Oct 6, 2026, 12:35 PM EDT

HUMA

Humacyte, Inc.

$84M

$0.50HealthcareDelayed quote: Oct 6, 2026, 12:35 PM EDT

Total return — CNXU vs HUMA

growth of $100 · dividends reinvested · last 1y

CNXU -76.1% (-76.1%/yr)HUMA -45.5% (-45.5%/yr)HUMA compounded faster over this window

CNXU HUMA

Metrics side by side

Total return (annualized)

Metric	CNXU	HUMA
Total return (1Y)	N/A	-76.03%
Total return CAGR (3Y)	N/A	-43.88%
Total return CAGR (5Y)	N/A	-45.73%

CNXU is an index fund, so valuation, profitability, and per-company growth metrics don't apply — the head-to-head here is total return (price plus reinvested dividends).

Go deeper

Full CNXU analysis Full HUMA analysis Interactive comparison tool

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.